ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
36.82
0.14%
US Tech 100
18,971.20
-0.03%
S&P 500
5,554.25
0.20%
US Dollar vs CAD
1.36806
-0.04%
Bitcoin
59,773.19
0.51%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Mangoceuticals Inc (MGRX)

  7. Mangoceuticals Inc (MGRX) News

MGRX

Mangoceuticals (MGRX)

Mangoceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:MGRX
DateTimeSourceHeadlineSymbolCompany
08/15/20248:25AMGlobeNewswire Inc.MangoRx Reports 1,685% Increase in Shareholders’ Equity From December 31, 2023, to $13.8MM, and 56% Increase in Year-Over-Year Revenue for First Half of 2024NASDAQ:MGRXMangoceuticals Inc
08/13/20243:00PMGlobeNewswire Inc.MangoRx Receives Certificate of Grant in India for its Respiratory Illness and Preventive Care Technology PatentNASDAQ:MGRXMangoceuticals Inc
08/09/20247:15AMGlobeNewswire Inc.MangoRx Completes Migration to DEA-Approved Telemedicine Platform, Accelerating Timeline of Oral Dissolvable GLP-1 Weight Loss Treatments Featuring Semaglutide and TirzepatideNASDAQ:MGRXMangoceuticals Inc
07/24/20247:15AMGlobeNewswire Inc.MangoRx Initiates Efficacy Studies on its Patented Respiratory Illness Prevention TechnologyNASDAQ:MGRXMangoceuticals Inc
07/18/20243:05PMGlobeNewswire Inc.Mangoceuticals CEO Jacob Cohen Featured on Benzinga All-AccessNASDAQ:MGRXMangoceuticals Inc
07/16/20247:20AMGlobeNewswire Inc.MangoRx Secures DEA Approval for Proprietary HIPAA-Compliant Operating System via SurescriptsNASDAQ:MGRXMangoceuticals Inc
07/12/202412:30PMGlobeNewswire Inc.MangoRx Appoints Dr. Douglas Christianson, N.D. as Director of the Medical Research and Product Innovation DepartmentNASDAQ:MGRXMangoceuticals Inc
07/11/20247:15AMGlobeNewswire Inc.MangoRx Announces Strategic Partnership for Expansion into Asia Pacific and Key Emerging MarketsNASDAQ:MGRXMangoceuticals Inc
06/18/20241:57PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:MGRXMangoceuticals Inc
06/10/202412:28PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:MGRXMangoceuticals Inc
06/06/20247:30AMGlobeNewswire Inc.MangoRx Receives Notice of Acceptance for Patent Application in Australia for Respiratory Illness and Preventive Care TechnologyNASDAQ:MGRXMangoceuticals Inc
06/05/20244:15PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MGRXMangoceuticals Inc
06/05/20244:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MGRXMangoceuticals Inc
06/05/20244:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MGRXMangoceuticals Inc
06/04/20243:00PMGlobeNewswire Inc.MangoRx Receives Patent Notice of Allowance in Japan for Revolutionary Preventive Care Technology Acquired from Intramont TechnologiesNASDAQ:MGRXMangoceuticals Inc
06/04/20247:00AMGlobeNewswire Inc.MangoRx to Introduce “MOJO” Pharmaceutical Compounded Formula Featuring Enclomiphene Citrate and Pregnenolone for Treatment of Low Testosterone and Male Hormone ImbalancesNASDAQ:MGRXMangoceuticals Inc
05/28/20247:30AMGlobeNewswire Inc.Mangoceuticals, Inc. Announces Completion of First Batch of Mango ED Products for Marketing and Distribution in Mexico and Latin American MarketsNASDAQ:MGRXMangoceuticals Inc
05/23/20247:30AMGlobeNewswire Inc.MangoRx Engages Renown International Digital and Performance Marketing Company Crakmedia to Champion its Digital Marketing EffortsNASDAQ:MGRXMangoceuticals Inc
05/21/20247:30AMGlobeNewswire Inc.MangoRx to Introduce Oral Semaglutide and Tirzepatide in Response to Increasing Patient Demand for GLP-1 MedicationsNASDAQ:MGRXMangoceuticals Inc
05/16/20243:40PMGlobeNewswire Inc.MangoRx Reports Revenue Growth of 108% in Q1 2024 Fueled by Amplified Customer Acquisition and Early Market PenetrationNASDAQ:MGRXMangoceuticals Inc
05/16/202412:59PMEdgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:MGRXMangoceuticals Inc
05/16/20248:19AMEdgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:MGRXMangoceuticals Inc
05/15/20243:52PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:MGRXMangoceuticals Inc
05/14/20248:00AMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:MGRXMangoceuticals Inc
05/09/202411:15PMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:MGRXMangoceuticals Inc
05/06/20244:32PMEdgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:MGRXMangoceuticals Inc
05/06/20243:43PMEdgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:MGRXMangoceuticals Inc
05/02/20247:00AMGlobeNewswire Inc.Mangoceuticals Granted 180-Day Extension to Meet Nasdaq Minimum Bid Price Requirement and Conditional Approval of Compliance with Nasdaq’s Minimum Stockholders’ Equity RequirementNASDAQ:MGRXMangoceuticals Inc
04/25/20247:30AMGlobeNewswire Inc.Mangoceuticals Acquires Global Patent Portfolio to Revolutionize Preventive CareNASDAQ:MGRXMangoceuticals Inc
04/12/20247:45AMGlobeNewswire Inc.Mangoceuticals Subsidiary, MangoRx Mexico, Executes Technical Agreement with Mexican Pharmaceutical Manufacturer for Initial Development and Production of its Mango Erectile Dysfunction (ED) ProductsNASDAQ:MGRXMangoceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:MGRX

Your Recent History

USOTC
ERHE
ERHC Energy (CE)
COIN
SHIBUSD
SHIBA INU
USOTC
CGAC
Code Green Apparel (PK)
USOTC
SPZI
Spooz (PK)
USOTC
VPLM
Voip Pal Com (QB)
USOTC
NSAV
Net Savings Link (PK)
USOTC
CEOS
CeCors (PK)
USOTC
ABQQ
AB (PK)
USOTC
HIRU
Hiru (PK)
NASDAQ
COOP
Mr Cooper
NASDAQ
AVXL
Anavex Life Sciences
USOTC
AHRO
Authentic (PK)
USOTC
IGPK
Intergrated Cannabis Sol... (PK)
NASDAQ
RVNC
Revance Therapeutics
USOTC
BIEL
Bioelectronics (PK)
USOTC
AABB
Asia Broadband (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved